The effect of isocapnic hyperventilation on early recovery after remifentanil/sevoflurane anesthesia in O2 /air: A randomized trial

Acta Anaesthesiol Scand. 2019 Apr;63(4):455-460. doi: 10.1111/aas.13293. Epub 2018 Nov 6.

Abstract

Background: Isocapnic hyperventilation (ICHV) may hasten emergence from general anesthesia but remains inadequately studied. We prospectively determined emergence time after sevoflurane anesthesia of variable duration with and without ICHV.

Methods: In 25 ASA I-II patients, general anesthesia was maintained with one age-adjusted MAC sevoflurane in O2 /air and target-controlled remifentanil delivery. At the start of skin closure, the remifentanil effect-site concentration was reduced to 1.5 ng/mL, any residual neuromuscular block reversed, and once the remifentanil effect-site concentration had decreased to 1.5 ng/mL, remifentanil and sevoflurane administration was stopped, and the fresh gas flow increased above minute ventilation. Patients randomly received either normoventilation (n = 13) or ICHV (doubling minute ventilation while titrating CO2 into the inspiratory limb to maintain isocapnia [n = 12]). Three early recovery end points were determined: time to proper response to verbal command; time to extubation; and time to stating one's name.

Results: Demographics were the same in both groups. Recovery end points were reached faster in the ICHV group compared to the normoventilation group: time to proper response to verbal command was 7.6 ± 2.2 vs 9.9 ± 2.9 min (P = 0.03); time to extubation was 7.6 ± 2.6 vs 11.0 ± 2.4 min (P = 0.002); and time to stating one's name was 8.9 ± 2.8 vs 12.5 ± 2.6 min (P = 0.003). Within each group, duration of anesthesia only marginally affected the times to reach these recovery end points.

Conclusion: Isocapnic hyperventilation only had a small effect on emergence times after anesthesia, suggesting that isocapnic hyperventilation may have limited clinical benefits with modern potent inhaled anesthetics.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Airway Extubation
  • Anesthesia Recovery Period*
  • Anesthesia, General*
  • Anesthetics, Inhalation
  • Anesthetics, Intravenous
  • Carbon Dioxide / blood*
  • Carbon Monoxide / pharmacology
  • Endpoint Determination
  • Female
  • Humans
  • Hyperventilation*
  • Male
  • Middle Aged
  • Oxygen / administration & dosage
  • Oxygen / pharmacology*
  • Remifentanil
  • Sevoflurane

Substances

  • Anesthetics, Inhalation
  • Anesthetics, Intravenous
  • Carbon Dioxide
  • Sevoflurane
  • Carbon Monoxide
  • Remifentanil
  • Oxygen